Articles Vol. 65 No. 6 30/10/2024

3. THE PREVALENCE AND RISK FACTORS FOR ORAL CANDIDIASIS IN HIV/AIDS PATIENTS AT THE CENTER FOR TROPICAL DISEASES, NGHE AN GENERAL FRIENDSHIP HOSPITAL (2022-2024)

Ngu Thi Tham1,2, Vu Van Du3,4, Que Anh Tram5,6
1 Thai Thuong Hoang Hospital
2 Bệnh viện Thái Thượng Hoàng
3 National Hospital of Obstetrics and Gynecology
4 Bệnh viện Phụ sản Trung ương
5 Center for Tropical Diseases, Nghe An Friendship General Hospital
6 Trung tâm Nhiệt đới Bệnh viện Hữu nghị Đa khoa Nghệ An
Corresponding author: ngutham93@gmail.com
DOI: 10.52163/yhc.v65i6.1560
20 Views
15 Downloads
Keywords
HIV/AIDS oral candidiasis
Abstract

Objectives: The study aims to describe the prevalence and related factors for oral candidiasis in HIV/AIDS patients.

Methods: Descriptive and analytical research method was employed.

Results: Among 393 HIV/AIDS inpatients and outpatients undergoing clinical examination and testing, the prevalence of oral candidiasis in HIV/AIDS patients was 10.7% (42/393). Factors related to oral candidiasis included: Number of dental cleanings: [9,057: 1,205- 68,075, p < 0,05]; Wearing dentures: [15.104:2.840-80.339, p < 0.01]; Inpatient treatment: [1.197:3.855 – 37.140, p < 0.01]; and HIV/AIDS stage: [8.363:2.217 – 31.552, p < 0.01].

Conclusions: The prevalence of oral candidiasis in HIV/AIDS patients was 10.7%. Oral hygiene, HIV/AIDS stage, denture wearing, and inpatient treatment were associated with oral candidiasis.

References
[1]
Đại học Y Hà Nội (2016). Bài giảng bệnh truyền nhiễm. Nhà XB Y học, Hà Nội Google Scholar
[2]
Nguyễn Ngọc Thiên Hương và CS (2007), Những tổn thương niêm mạc miệng liên quan với nhiễm HIV ở người cai nghiện ma túy, Tạp chí Y học Tp. Hồ Chí Minh. Tập11 (2), Tr.200- 205 Google Scholar
[3]
Kwamin F, Nartey NO, Codjoe FS, et al. Distribution of Candida species among HIV-positive patients with oropharyngeal Candidiasis in Accra, Ghana. J Infect Dev Ctries 2013; 7: 41–45. Crossref. PubMed. Google Scholar
[4]
Taverne-Ghadwal L, Kuhns M, Buhl T, et al. Epidemiology and prevalence of oral Candidiasis in HIV patients from Chad in the Post-HAART Era. Front Microbiol 2022; 13: 844069. Crossref. PubMed. Google Scholar
[5]
Mulu A, Kassu A, Anagaw B, et al. Frequent detection of ‘azole ’ resistant Candida species among late presenting AIDS patients in northwest Ethiopia. BMC Infect Dis 2013; 13: 82. Crossref. PubMed. ISI. Google Scholar
[6]
Ambe NF, Longdoh NA, Tebid P, et al. The prevalence, risk factors and antifungal sensitivity pattern of oral Candidiasis in HIV/AIDS patients in Kumba District Hospital, South West Region, Cameroon. Pan Afr Med J 2020; 36: 23. Crossref. PubMed. Google Scholar
[7]
Agwu E, Ihongbe JC, McManus BA, et al. Distribution of yeast species associated with oral lesions in HIV-infected patients in Southwest Uganda. Med Mycol 2012; 50: 276–280. Crossref. PubMed Google Scholar
[8]
UNAIDS (2023). UNAIDS data 2023, from https://www.unaids.org/en/resources/fact-sheet Google Scholar
[9]
Bộ y tế (2024). Cục phòng, chống HIV/AIDS https://vaac.gov.vn/files/qd-612-ban-hanh-khphong-chong-HIV-2024-1.pdf Google Scholar
[10]
Maeve M. Coogan end et al (2005). Oral lesions in infection with human immunodeficiency virus. Google Scholar
[11]
H. K. Kroemer end et al (2015), Epidemiology and prevalence of oral Candidiasis in HIV patients from Chad. Google Scholar